Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S3 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer
  1. Home
  2. Publications
  3. Supplementary Table S3 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer

Supplementary Table S3 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer

Authors:
  • ACAtish D. Choudhury
    Atish D. Choudhury
  • CZCaiwei Zhong
    Caiwei Zhong
  • WXWanling Xie
    Wanling Xie
  • BKBose S. Kochupurakkal
    Bose S. Kochupurakkal
  • PWPeter I-Fan Wu
    Peter I-Fan Wu
  • IRIrbaz Bin Riaz
    Irbaz Bin Riaz
  • RLRuolin Liu
    Ruolin Liu
  • DYDavid D. Yang
    David D. Yang
  • EFEdmund Folefac
    Edmund Folefac
  • DLDaniel Lee
    Daniel Lee
  • MPMamta Parikh
    Mamta Parikh
  • DEDavid J. Einstein
    David J. Einstein

Open Access
Publisher website
Google Scholar
  • 18 September 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.33923280
Abstract
TrAE among 14 patients after crossover from Arm A to Arm B (worst grade by patient and toxicity type)
Keywords
  • SUPPLEMENTARY TABLE
  • PROSTATE CANCER
  • CARBOPLATIN COMPARED
  • METASTATIC CASTRATION-RESISTANT
  • CASTRATION-RESISTANT PROSTATE
  • CANCER TRAE
  • WORST GRADE
  • TOXICITY TYPE
  • CARBOPLATIN
  • ARM
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.